🔴 Recursion Pharmaceuticals is trading 4.04% down today as inflation and rate-hike bets pressured growth shares

Recursion Pharmaceuticals is trading at $3.68, down -4.04%, as hotter-than-expected September inflation and rising rate-hike bets pressured growth-sensitive shares.

• Reuters reported U.S. stocks fell on October 14; the S&P 500 declined 1.33%, while the Nasdaq fell 2.03%.
• No clear company-specific catalyst was identified for the October 14 decline; prior-session biotech weakness is secondary context.